CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Vegfr-2 in late stage/high grade squamous cell carcinoma of the lung: A cohort study

Author: 
Qazi Danish, Taseem A. Mokhdomi, Shoiab Bukhari, Azra Shah, Raies A. Qadri
Subject Area: 
Health Sciences
Abstract: 

Background: VEGFR-2 is a critical molecule for tumor angiogenesis and a target for assessment of anti-angiogenic therapy. Although, its expression and functionality has been correlated in various cancers, not many studies are available in the context of lung cancer. Patients and Methods: In this study, the expression of VEGFR-2 was analyzed in clinically relevant tissue samples of Non-Small Cell Lung Cancer (NSCLC) patients (n=108, surgically resected archival tumor samples) with histopathologically confirmed Squamous Cell Carcinoma (SCC) sub-type and compared with appropriate controls. Expression of endogenous level of VEGFR-2 was assessed by Western blotting and densitometry. Results: Clinicopathological data suggested that the incidence of SCC in local population with respect to age, sex, tumor stage and histology was typical and consistent with reported global incidence of NSCLC. We observed differential expression of VEGFR-2 based on the staging of tumors. Poorly differentiated SCC samples show higher expression of VEGFR-2, expression levels of VEGFR-2 in moderately differentiated SCC were comparable while expression was lower in well differentiated SCC samples when compared to their available respective controls. Further corroborating this observation, external control samples (non-tumor patient samples) expressed VEGFR-2 levels comparable to patient tissue controls in turn pointing to a possible stage-based prognostic significance for SCC. Conclusion: Our results highlight a strong correlation of VEGFR-2 expression, with late stage SCC compared to early stage SCC. Thus, VEGFR-2 may be actively involved in late progression of SCC, which constitutes a major chunk of NSCLC and may also have prognostic and therapeutic relevance.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran